NIFTY LargeMidcap 250

HDFC Asset Management Company has informed that the Share Allotment Committee of the Company vide circular resolutions passed on October 22, 2026, approved the following allotments: (i) 17,908 Equity Shares of Rs 5 each of the Company bearing distinctive numbers from 42,90,73,399 to 42,90,91,306 (both numbers inclusive) pursuant to exercise of Stock Options by eligible employees under Employees Stock Option Scheme - 2020 of the Company; and (ii) 72 Equity Shares of Rs 5 each of the Company bearing distinctive numbers from 42,90,91,307 to 42,90,91,378 (both numbers inclusive) pursuant to exercise of Stock Options by eligible employee under Employees Stock Options and Performance-linked Stock Units Scheme -2025 (‘ESOP & PSU Scheme - 2025’) of the Company. Post above allotment, the paid-up share capital of the Company is Rs 2,14,54,56,890 consisting 42,90,91,378 Equity Shares of Rs 5 each.

The above information is a part of company’s filings submitted to BSE.

Ipca Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 consider and approve Standalone and Consolidated Unaudited Financial Results for the second quarter and half year ended 30.09.2026,

The above information is a part of company’s filings submitted to BSE.

360 ONE WAM has informed that pursuant to conversion of all the warrants held by the Allottee and upon receipt of Rs. 1583,85,20,377.50/- i.e. the balance 75% of the warrant exercise price from the allottee, the Stakeholders Relationship Committee of the Board of Directors of the Company vide resolution passed by circulation on October 22, 2026, has allotted 2,05,02,939 equity shares of face value of Re. 1/- each to UBS AG at an issue price of Rs. 1,030/- per equity share. The equity shares allotted on conversion shall rank pari passu with the existing equity shares of the Company in all respects. Consequent to the aforesaid allotment, the issued, subscribed and paid-up share capital of the Company has increased from Rs. 40,79,14,200/- comprising of 40,79,14,200 equity shares of Re. 1 each, to Rs. 42,84,17,139/- comprising of 42,84,17,139 equity shares of Re. 1/- each. Further, it enclosed the details pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with point A(2) of annexure 18 of SEBI Master Circular dated January 30, 2026, with respect to issue of equity shares, as ‘Annexure 1’ and a Press Release in this regard as ‘Annexure 2’.

The above information is a part of company’s filings submitted to BSE.

Coal India has informed that a meeting of Board of Directors of the company will be held on Thursday, 29th October’ 2026 to consider, approve and take on record the Un-Audited Financial Results of the Company (Standalone & Consolidated) for the 2nd quarter and half year ended 30th Sep’ 2026 after the results are reviewed by the Audit Committee of CIL Board. Further, pursuant to Regulation 29 of the Listing Regulations 2015, notice is also given that Board of Directors of the company may also, consider and declare payment of 2nd Interim Dividend for FY 2026-27, if any.

The above information is a part of company’s filings submitted to BSE